Hong Kong – Greater Bay Area Deep Dive will take place on Tuesday, September 3rd, 2024, at 10am London / 11am Paris / 5pm Hong Kong. Join us for a focused 1-hour webinar that will provide you with the insights needed to leverage the GBA pathway effectively.
Webinar Highlights
- Discover how Hong Kong is positioned as a critical gateway for international companies looking to enter the GBA market, with insights from Andy Wong of InvestHK.
- Dr Grace Lau from the Institute for Translational Research will share insights into key projects supported by HKSTP, including collaborations with leading global MedTech firms such as AstraZeneca, Boehringer Ingelheim and Roche
- Case Studies & Regulatory Reform: Understand the ‘+1’ Mechanism with practical examples, get updated on newly streamlined regulations, and see how companies are successfully navigating the GBA landscape.
Webinar Details
Date: Tuesday, September 3rd, 2024
Time: 10am BST / 11am CEST / 5 PM HKT
Duration: 1 hour
Language: English
Hosted by: Cisema
Speakers
- Jacky Li – Regulatory Lead Hong Kong, Cisema
- Dr Grace Lau – Head of Institute for Translational Research, HKSTP
- Andy Wong – Head of Innovation and Technology, InvestHK
- Anthony Barker – Sales Director, Cisema
If you can’t attend the live session, a full replay will be available for a limited period, but you’ll miss the chance to ask questions directly to our speakers.
Further information
This webinar draws on our practical experience with Hong Kong and GBA regulatory approvals, providing comprehensive guidance on identifying the requirements and necessary steps to take during the application process. If you want to know more about our services for pharmaceutical registration or medical device listing in Hong Kong, feel free to reach out to us.
GET IN TOUCH
